Contergan oder die Macht der Arzneimittelkonzerne:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
Berlin
Volk u. Gesundheit
1975
|
| Schlagworte: | |
| Beschreibung: | EST: Thalidomide and the power of the drug companies (dt.) |
| Beschreibung: | 261 S. |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV007376567 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 930421s1975 |||| 00||| ger d | ||
| 035 | |a (OCoLC)312732747 | ||
| 035 | |a (DE-599)BVBBV007376567 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-355 |a DE-83 |a DE-11 |a DE-2070s |a DE-578 |a DE-Bo133 |a DE-B496 | ||
| 084 | |a VB 2100 |0 (DE-625)146997: |2 rvk | ||
| 100 | 1 | |a Sjöström, Henning |e Verfasser |4 aut | |
| 240 | 1 | 0 | |a Thalidomide and the power of the drug companies |
| 245 | 1 | 0 | |a Contergan oder die Macht der Arzneimittelkonzerne |c Henning Sjöström ; Robert Nilsson* |
| 264 | 1 | |a Berlin |b Volk u. Gesundheit |c 1975 | |
| 300 | |a 261 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a EST: Thalidomide and the power of the drug companies (dt.) | ||
| 650 | 7 | |a Arzneimittel |2 fes | |
| 650 | 7 | |a Arzneimittelindustrie |2 fes | |
| 650 | 7 | |a Krankheit |2 fes | |
| 650 | 0 | 7 | |a Nebenwirkung |0 (DE-588)4317914-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Thalidomid |0 (DE-588)4184973-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Thalidomid |0 (DE-588)4184973-5 |D s |
| 689 | 0 | 1 | |a Nebenwirkung |0 (DE-588)4317914-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Nilsson, Robert |e Verfasser |4 aut | |
| 940 | 1 | |q TUB-nveb | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-004764079 | ||
Datensatz im Suchindex
| _version_ | 1804121627449884672 |
|---|---|
| any_adam_object | |
| author | Sjöström, Henning Nilsson, Robert |
| author_facet | Sjöström, Henning Nilsson, Robert |
| author_role | aut aut |
| author_sort | Sjöström, Henning |
| author_variant | h s hs r n rn |
| building | Verbundindex |
| bvnumber | BV007376567 |
| classification_rvk | VB 2100 |
| ctrlnum | (OCoLC)312732747 (DE-599)BVBBV007376567 |
| discipline | Chemie / Pharmazie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01352nam a2200397 c 4500</leader><controlfield tag="001">BV007376567</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930421s1975 |||| 00||| ger d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)312732747</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV007376567</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-2070s</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-Bo133</subfield><subfield code="a">DE-B496</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VB 2100</subfield><subfield code="0">(DE-625)146997:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sjöström, Henning</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="240" ind1="1" ind2="0"><subfield code="a">Thalidomide and the power of the drug companies</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Contergan oder die Macht der Arzneimittelkonzerne</subfield><subfield code="c">Henning Sjöström ; Robert Nilsson*</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">Volk u. Gesundheit</subfield><subfield code="c">1975</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">261 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">EST: Thalidomide and the power of the drug companies (dt.)</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="2">fes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittelindustrie</subfield><subfield code="2">fes</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Krankheit</subfield><subfield code="2">fes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Thalidomid</subfield><subfield code="0">(DE-588)4184973-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Thalidomid</subfield><subfield code="0">(DE-588)4184973-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nebenwirkung</subfield><subfield code="0">(DE-588)4317914-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nilsson, Robert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">TUB-nveb</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-004764079</subfield></datafield></record></collection> |
| id | DE-604.BV007376567 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:00:59Z |
| institution | BVB |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-004764079 |
| oclc_num | 312732747 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-83 DE-11 DE-2070s DE-578 DE-Bo133 DE-B496 |
| owner_facet | DE-355 DE-BY-UBR DE-83 DE-11 DE-2070s DE-578 DE-Bo133 DE-B496 |
| physical | 261 S. |
| psigel | TUB-nveb |
| publishDate | 1975 |
| publishDateSearch | 1975 |
| publishDateSort | 1975 |
| publisher | Volk u. Gesundheit |
| record_format | marc |
| spelling | Sjöström, Henning Verfasser aut Thalidomide and the power of the drug companies Contergan oder die Macht der Arzneimittelkonzerne Henning Sjöström ; Robert Nilsson* Berlin Volk u. Gesundheit 1975 261 S. txt rdacontent n rdamedia nc rdacarrier EST: Thalidomide and the power of the drug companies (dt.) Arzneimittel fes Arzneimittelindustrie fes Krankheit fes Nebenwirkung (DE-588)4317914-9 gnd rswk-swf Thalidomid (DE-588)4184973-5 gnd rswk-swf Thalidomid (DE-588)4184973-5 s Nebenwirkung (DE-588)4317914-9 s DE-604 Nilsson, Robert Verfasser aut |
| spellingShingle | Sjöström, Henning Nilsson, Robert Contergan oder die Macht der Arzneimittelkonzerne Arzneimittel fes Arzneimittelindustrie fes Krankheit fes Nebenwirkung (DE-588)4317914-9 gnd Thalidomid (DE-588)4184973-5 gnd |
| subject_GND | (DE-588)4317914-9 (DE-588)4184973-5 |
| title | Contergan oder die Macht der Arzneimittelkonzerne |
| title_alt | Thalidomide and the power of the drug companies |
| title_auth | Contergan oder die Macht der Arzneimittelkonzerne |
| title_exact_search | Contergan oder die Macht der Arzneimittelkonzerne |
| title_full | Contergan oder die Macht der Arzneimittelkonzerne Henning Sjöström ; Robert Nilsson* |
| title_fullStr | Contergan oder die Macht der Arzneimittelkonzerne Henning Sjöström ; Robert Nilsson* |
| title_full_unstemmed | Contergan oder die Macht der Arzneimittelkonzerne Henning Sjöström ; Robert Nilsson* |
| title_short | Contergan oder die Macht der Arzneimittelkonzerne |
| title_sort | contergan oder die macht der arzneimittelkonzerne |
| topic | Arzneimittel fes Arzneimittelindustrie fes Krankheit fes Nebenwirkung (DE-588)4317914-9 gnd Thalidomid (DE-588)4184973-5 gnd |
| topic_facet | Arzneimittel Arzneimittelindustrie Krankheit Nebenwirkung Thalidomid |
| work_keys_str_mv | AT sjostromhenning thalidomideandthepowerofthedrugcompanies AT nilssonrobert thalidomideandthepowerofthedrugcompanies AT sjostromhenning conterganoderdiemachtderarzneimittelkonzerne AT nilssonrobert conterganoderdiemachtderarzneimittelkonzerne |